C. Rychlicki

1.7k total citations
29 papers, 1.4k citations indexed

About

C. Rychlicki is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Rychlicki has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Rychlicki's work include Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (6 papers) and Pancreatic function and diabetes (6 papers). C. Rychlicki is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (6 papers) and Pancreatic function and diabetes (6 papers). C. Rychlicki collaborates with scholars based in Italy, United States and Spain. C. Rychlicki's co-authors include Gianluca Svegliati‐Baroni, A. Benedetti, S. Saccomanno, C. Candelaresi, Laura Agostinelli, Samuele De Minicis, Marco Marzioni, L. Trozzi, E. Mingarelli and Amalia Gastaldelli and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

C. Rychlicki

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Rychlicki Italy 15 771 519 441 382 293 29 1.4k
Jamie E. Mells United States 10 987 1.3× 447 0.9× 675 1.5× 464 1.2× 205 0.7× 11 1.5k
C. Candelaresi Italy 20 952 1.2× 587 1.1× 505 1.1× 488 1.3× 478 1.6× 31 1.8k
Laura Agostinelli Italy 13 645 0.8× 444 0.9× 509 1.2× 365 1.0× 234 0.8× 18 1.2k
Patricia Aspichueta Spain 21 778 1.0× 585 1.1× 366 0.8× 217 0.6× 160 0.5× 51 1.5k
Michael Feigh Denmark 19 897 1.2× 430 0.8× 607 1.4× 275 0.7× 264 0.9× 58 1.4k
Tsuyoshi Yoshimoto Japan 13 826 1.1× 397 0.8× 399 0.9× 189 0.5× 224 0.8× 34 1.3k
María E. Miquilena-Colina Spain 14 1.0k 1.4× 449 0.9× 361 0.8× 227 0.6× 178 0.6× 16 1.5k
Fahrettin Haczeyni Australia 8 939 1.2× 654 1.3× 281 0.6× 193 0.5× 285 1.0× 8 1.4k
Derrick M. Van Rooyen Australia 11 1.3k 1.6× 699 1.3× 449 1.0× 300 0.8× 391 1.3× 12 1.8k
Cristiana Bertolani Italy 12 1.0k 1.4× 265 0.5× 251 0.6× 234 0.6× 514 1.8× 15 1.5k

Countries citing papers authored by C. Rychlicki

Since Specialization
Citations

This map shows the geographic impact of C. Rychlicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rychlicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rychlicki more than expected).

Fields of papers citing papers by C. Rychlicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rychlicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rychlicki. The network helps show where C. Rychlicki may publish in the future.

Co-authorship network of co-authors of C. Rychlicki

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rychlicki. A scholar is included among the top collaborators of C. Rychlicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rychlicki. C. Rychlicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petta, Salvatore, Luca Valenti, Gianluca Svegliati‐Baroni, et al.. (2017). Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2660–2669. 45 indexed citations
2.
Bartolini, Desirée, Pierangelo Torquato, Carolina Barola, et al.. (2017). Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E). The Journal of Nutritional Biochemistry. 47. 120–131. 41 indexed citations
3.
Pierantonelli, I., C. Rychlicki, Laura Agostinelli, et al.. (2017). Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Scientific Reports. 7(1). 12200–12200. 64 indexed citations
4.
Maroni, Luca, Laura Agostinelli, S. Saccomanno, et al.. (2016). Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes. American Journal Of Pathology. 187(2). 366–376. 53 indexed citations
5.
Ceccarelli, Sara, Nadia Panera, Marco Mina, et al.. (2015). LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease. Oncotarget. 6(39). 41434–41452. 112 indexed citations
6.
Minicis, Samuele De, Laura Agostinelli, C. Rychlicki, et al.. (2014). HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH. PLoS ONE. 9(5). e97136–e97136. 81 indexed citations
7.
Marzioni, Marco, Ugo Germani, Laura Agostinelli, et al.. (2014). PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer. Digestive and Liver Disease. 47(2). 138–143. 6 indexed citations
8.
Marzioni, Marco, Laura Agostinelli, C. Candelaresi, et al.. (2014). Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. Hepatology. 60(4). 1324–1335. 15 indexed citations
9.
Minicis, Samuele De, C. Rychlicki, Laura Agostinelli, et al.. (2013). Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice. Hepatology. 59(5). 1738–1749. 231 indexed citations
10.
Minicis, Samuele De, C. Rychlicki, Laura Agostinelli, et al.. (2013). Semaphorin 7A Contributes to TGF-β–Mediated Liver Fibrogenesis. American Journal Of Pathology. 183(3). 820–830. 42 indexed citations
11.
Marzioni, Marco, Ugo Germani, Laura Agostinelli, et al.. (2013). 198 PDX-1 mRNA Expression in Endoscopic Ultrasound-Guided Fine Needle Cytoaspirate As a New Marker for the Diagnosis of Pancreatic Cancer. Gastrointestinal Endoscopy. 77(5). AB135–AB135. 1 indexed citations
12.
Minicis, Samuele De, C. Candelaresi, Laura Agostinelli, et al.. (2012). Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution. Liver International. 32(10). 1574–1584. 39 indexed citations
13.
Marzioni, Marco, S. Saccomanno, Laura Agostinelli, et al.. (2012). PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: Possible implications for sclerosing cholangitis. Journal of Hepatology. 58(4). 750–756. 22 indexed citations
14.
Minicis, Samuele De, Marco Marzioni, S. Saccomanno, et al.. (2011). Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer. 1(1). 88–94. 14 indexed citations
15.
Svegliati‐Baroni, Gianluca, S. Saccomanno, C. Rychlicki, et al.. (2011). Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis. Liver International. 31(9). 1285–1297. 344 indexed citations
16.
Marzioni, Marco, S. Saccomanno, C. Candelaresi, et al.. (2010). Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. Journal of Hepatology. 53(4). 663–670. 12 indexed citations
17.
Marzioni, Marco, S. Saccomanno, C. Candelaresi, et al.. (2010). Clinical implications of novel aspects of biliary pathophysiology. Digestive and Liver Disease. 42(4). 238–244. 10 indexed citations
18.
Marzioni, Marco, Pietro Invernizzi, C. Candelaresi, et al.. (2008). Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth. Digestive and Liver Disease. 41(7). 523–533. 11 indexed citations
19.
Marzioni, Marco, Gianfranco Alpini, S. Saccomanno, et al.. (2008). Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis. Gut. 58(7). 990–997. 55 indexed citations
20.
Marzioni, Marco, Gianfranco Alpini, S. Saccomanno, et al.. (2007). Glucagon-Like Peptide-1 and Its Receptor Agonist Exendin-4 Modulate Cholangiocyte Adaptive Response to Cholestasis. Gastroenterology. 133(1). 244–255. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie E. Mells Breakdown of academic impact, for papers by C. Candelaresi Breakdown of academic impact, for papers by Laura Agostinelli Breakdown of academic impact, for papers by Patricia Aspichueta Breakdown of academic impact, for papers by Michael Feigh Breakdown of academic impact, for papers by Tsuyoshi Yoshimoto Breakdown of academic impact, for papers by María E. Miquilena-Colina Breakdown of academic impact, for papers by Fahrettin Haczeyni Breakdown of academic impact, for papers by Derrick M. Van Rooyen Breakdown of academic impact, for papers by Cristiana Bertolani
Rankless by CCL
2026